Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical and immunological impact of HIV envelope V3 sequence variation after starting initial triple antiretroviral therapy.

AIDS (London, England) - 5 Mar 2004

Brumme Zabrina L, Dong Winnie W Y, Yip Benita, Wynhoven Brian, Hoffman Noah G, Swanstrom Ronald, Jensen Mark A, Mullins James I, Hogg Robert S, Montaner Julio S G, Harrigan P Richard

Abstract excerpt

BACKGROUND: The HIV-1 envelope third variable loop (V3 loop) is an important determinant of viral phenotype and co-receptor usage. We wished to determine the impact of specific V3 genotypes associated with viral phenotype and co-receptor usage on response to initial triple antiretroviral therapy....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiretroviral Therapy, Highly Active
Share to CD4 Lymphocyte Count

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to HIV Envelope Protein gp120

Share to Neural Networks, Computer

Share to Peptide Fragments

Share to Survival Analysis

Share to Viral Load

Source

Identifiers

PMID: 15090786
DOI: 10.1097/00002030-200403050-00001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-15090786-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical and immunological impact of HIV envelope V3 sequence variation after starting initial triple antiretroviral therapy.PMID 15090786Read ↗

Predicting HIV-1 coreceptor usage with sequence analysis.Semantic proximity Read ↗

Predicting HIV coreceptor usage on the basis of genetic and clinical covariates.Semantic proximity Read ↗

A new perspective on V3 phenotype prediction.Semantic proximity Read ↗

Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism.Semantic proximity Read ↗

Genetic determinants in HIV-1 Gag and Env V3 are related to viral response to combination antiretroviral therapy with a protease inhibitor.Semantic proximity Read ↗

Improved success of phenotype prediction of the human immunodeficiency virus type 1 from envelope variable loop 3 sequence using neural networks.Semantic proximity Read ↗

Current V3 genotyping algorithms are inadequate for predicting X4 co-receptor usage in clinical isolates.Semantic proximity Read ↗

Envelope V3 amino acid sequence predicts HIV-1 phenotype (co-receptor usage and tropism for macrophages).Semantic proximity Read ↗

Identification and structural characterization of novel genetic elements in the HIV-1 V3 loop regulating coreceptor usage.Semantic proximity Read ↗

Molecular and clinical epidemiology of CXCR4-using HIV-1 in a large population of antiretroviral-naive individuals.Semantic proximity Read ↗

A reliable phenotype predictor for human immunodeficiency virus type 1 subtype C based on envelope V3 sequences.Semantic proximity Read ↗

Variability in the human immunodeficiency virus type 1 gp120 Env protein linked to phenotype-associated changes in the V3 loop.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.